Research summary, original research, 2021

Radiation Awareness for EVAR in Hybrid Operating Room: An Instant Operator Risk Chart

de Ruiter QMB, Moll FL, Hazenberg CEVB, van Herwaarden JA. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. 2021

Read the original paper

In plain language

In 50 endovascular aneurysm repair (EVAR) procedures in one hybrid OR, operator dose rates rose disproportionately with C-arm rotation and roughly 2.5-3 fold with brachial versus femoral access. These are over-apron dosimeter readings, not health outcomes.

At a glance

Type of study
Original research, Dosimetry measurement study
Who was studied
Vascular surgeons, Patients
Size
n = 12,865 X-ray acquisitions (from 50 patients)
Summary based on
the full text

What it found

  • Switching from femoral to brachial access markedly increased operator dose rate, far more than patient dose rate.

    Key figures: Odds ratio (OR) 2.5 [2.32-2.67] for operator vs 1.05 for patient (fluoroscopy)

  • C-arm rotation increased operator dose rate disproportionately compared with patient dose rate.

    Key figures: 69% (fluoroscopy) and 85% (DSA) per 30° vs 24% and 37% for patient

  • Predicted time to reach 20 mSv annual limit during 2 fps DSA was much shorter from brachial than femoral access.

    Key figures: 941 minutes femoral vs 358 minutes brachial

  • DSA acquisitions gave much higher operator dose rates than fluoroscopy.

    Key figures: median 0.833 mSv/h DSA vs 0.119 mSv/h fluoroscopy

  • Replacing 2 fps DSA with a fluoroscopy roadmap reduced operator dose rate.

    Key figures: effect size 0.45 (55% reduction)

Limits to keep in mind

Single hybrid OR, 50 patients, two operators with a single over-apron chest dosimeter (no eye lens dose, positions and shield placement not recorded); low-dose runs below detector range were excluded, and operator models explained limited variance (r2 0.38-0.48).

How this summary was made

ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.